{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-096532","form_type":"8-K","ticker":"APTN","cik":"0001938571","company_name":"ADAPTIN BIO, INC.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.110825+00:00","generated_at":"2026-05-17T04:38:31.095008+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Adaptin Bio increases CFO salary to $300k full-time; CDO salary to $150k at 50% commitment","bullets":["CFO Timothy Maness moved to full-time from 80%; base salary raised from $240k to $300k, retroactive to July 1, 2025.","CDO L. Arthur Hewitt commitment increased from 25% to 50%; salary doubled to $150k annually, effective October 3, 2025.","Hewitt amendment includes anti-dilution option grant if company raises $10M within two years of February 11, 2025 merger.","Both amendments effective as of specified dates; no other material changes to employment terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-096532","json":"https://secwatch.observer/filing/0001213900-25-096532.json","markdown":"https://secwatch.observer/filing/0001213900-25-096532.md","text":"https://secwatch.observer/filing/0001213900-25-096532.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025096532/0001213900-25-096532-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025096532/ea0260272-8k_adaptin.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:38:31.095008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}